Lenalidomide After Donor Stem Cell Transplant and Bortezomib in Treating Patients With High Risk Multiple Myeloma
Clinical trial NCT01954784 · TERMINATED
Trial details
- NCT number
- NCT01954784
- Sponsor
- Case Comprehensive Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-07
- Primary completion
- 2017-01-30
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.